Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts

NCT02967666 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT02967666
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967666 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed Contacts
Lead sponsor
National University Hospital, Singapore
Phase
Phase 1
Overall status
Unknown status
Start date
November 30, 2016
Completion date
Not reported
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary